A Clinico-Dermoscopic Approach for Skin Cancer Screening. Recommendations Involving a Survey of the International Dermoscopy Society.

Dermatologic Clinics

Volumn 31, Issue 4, 2013, Pages 525-534

  Argenziano, Giuseppe ^a   Giacomel, Jason ^b   Zalaudek, Iris ^a   Blum, Andreas ^c   Braun, Ralph P ^d   Cabo, Horacio ^e   Halpern, Allan ^f   Hofmann Wellenhof, Rainer ^g   Malvehy, Josep ^h   Marghoob, Ashfaq A ^f   Menzies, Scott ⁱ   Moscarella, Elvira ^a   Pellacani, Giovanni ^j   Puig, Susana ^h   Rabinovitz, Harold ^k   Saida, Toshiaki ^l   Seidenari, Stefania ^j   Soyer, H Peter ^m   Stolz, Wilhelm ⁿ   Thomas, Luc ^o   Kittler, Harald ^p   more..

^a S MARIA NUOVA HOSPITAL   (Italy)

^b Skin Spectrum Medical Services   (Australia)

^c Public Private and Teaching Practice of Dermatology   (Germany)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m PRINCESS ALEXANDRA HOSPITAL   (Australia)

ⁿ Klinikum Schwabing   (Germany)

^o UNIVERSITÉ LYON 1   (France)

^p Universitatsklinik fur Dermatologie   (Austria)

more..

Author keywords

Clinical diagnosis; Dermatoscopy; Dermoscopy; Melanoma; Skin cancer; Triage

Indexed keywords

ADULT; CANCER SCREENING; DERMATOLOGIST; DIAGNOSTIC ACCURACY; E-MAIL; EMERGENCY HEALTH SERVICE; EPILUMINESCENCE MICROSCOPY; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; MALE; MEDICAL SOCIETY; MEDICAL SPECIALIST; NURSE; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RESIDENT; REVIEW; SKIN CANCER;

CLINICAL DIAGNOSIS; DERMATOSCOPY; DERMOSCOPY; MELANOMA; SKIN CANCER; TRIAGE;

ADULT; DERMOSCOPY; FEMALE; HEALTH CARE SURVEYS; HUMANS; INCIDENCE; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; PREVALENCE; RISK FACTORS; SKIN NEOPLASMS;

EID: 84884703510     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2013.06.001     Document Type: Review

References (42)

1. Cox N.H. Evaluation of the U.K. 2-week referral rule for skin cancer. Br J Dermatol 2004, 150:291-298.
2. Baughan P., Keatings J., O'Neill B. Urgent suspected cancer referrals from general practice: audit of compliance with guidelines and referral outcomes. Br J Gen Pract 2011, 61:700-706.
3. Marsden J.R., Newton-Bishop J.A., Burrows L., et al. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 2010, 163:238-256.
4. Australian Cancer Network Melanoma Guidelines Revision Working Party Clinical practice guidelines for the management of melanoma in Australia and New Zealand 2008, Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington (New Zeland).
5. May C., Giles L., Gupta G. Prospective observational comparative study assessing the role of store and forward teledermatology triage in skin cancer. Clin Exp Dermatol 2008, 33:736-739.
6. Tsang M.W., Resneck J.S. Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. JAm Acad Dermatol 2006, 55:54-58.
7. Bafounta M.L., Beauchet A., Aegerter P., et al. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001, 137:1343-1350.
8. Kittler H., Pehamberger H., Wolff K., et al. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002, 3:159-165.
9. Argenziano G., Soyer H.P., Chimenti S., et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. JAm Acad Dermatol 2003, 48:679-693.
10. Carli P., De Giorgi V., Chiarugi A., et al. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. JAm Acad Dermatol 2004, 50:683-689.
11. Carli P., De Giorgi V., Crocetti E., et al. Improvement ofmalignant/benign ratio in excised melanocytic lesions in the "dermoscopy era": a retrospective study 1997-2001. Br J Dermatol 2004, 150:687-692.
12. Vestergaard M.E., Macaskill P., Holt P.E., et al. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008, 159:669-676.
13. Argenziano G., Cerroni L., Zalaudek I., et al. Accuracy in melanoma detection: a 10-year multicenter survey. JAm Acad Dermatol 2011, 67(1):54-59.
14. Zalaudek I., Kittler H., Marghoob A.A., et al. Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch Dermatol 2008, 144:509-513.
15. Argenziano G., Ferrara G., Francione S., et al. Dermoscopy-the ultimate tool for melanoma diagnosis. Semin Cutan Med Surg 2009, 28:142-148.
16. Kittler H., Seltenheim M., Dawid M., et al. Morphologic changes of pigmented skin lesions: a useful extension of the ABCD rule for dermatoscopy. JAm Acad Dermatol 1999, 40:558-562.
17. Menzies S.W., Emery J., Staples M., et al. Impact ofdermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol 2009, 161:1270-1277.
18. Malvehy J., Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol 2002, 20:297-304.
19. Federman D.G., Kravetz J.D., Kirsner R.S. Skin cancer screening by dermatologists: prevalence and barriers. JAm Acad Dermatol 2002, 46:710-714.
20. Breitbart E.W., Waldmann A., Nolte S., et al. Systematic skin cancer screening in Northern Germany. JAm Acad Dermatol 2012, 66:201-211.
21. Geller A.C., O'Riordan D.L., Oliveria S.A., et al. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. JAm Board Fam Pract 2004, 17:416-423.
22. Geller A.C., Koh H.K., Miller D.R., et al. Use of health services before the diagnosis of melanoma: implications for early detection and screening. JGen Intern Med 1992, 7:154-157.
23. Argenziano G., Zalaudek I., Hofmann-Wellenhof R., et al. Total body skin examination for skin cancer screening in patients with focused symptoms. JAm Acad Dermatol 2012, 66:212-219.
24. Quéreux G., Moyse D., Lequeux Y., et al. Development of an individual score for melanoma risk. Eur J Cancer Prev 2011, 20:217-224.
25. Altamura D., Avramidis M., Menzies S.W. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol 2008, 144:502-506.
26. Suh K.Y., Bolognia J.L. Signature nevi. JAm Acad Dermatol 2009, 60:508-514.
27. Scope A., Dusza S.W., Halpern A.C., et al. The "ugly duckling" sign: agreement between observers. Arch Dermatol 2008, 144:58-64.
28. Argenziano G., Catricalà C., Ardigo M., et al. Dermoscopy of patients with multiple nevi: improved management recommendations using a comparative diagnostic approach. Arch Dermatol 2011, 147:46-49.
29. Haenssle H.A., Korpas B., Hansen-Hagge C., et al. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol 2010, 146:257-264.
30. Haenssle H.A., Krueger U., Vente C., et al. Results froman observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. JInvest Dermatol 2006, 126:980-985.
31. Kittler H., Guitera P., Riedl E., et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol 2006, 142:1113-1119.
32. Kittler H., Binder M. Risks and benefits of sequential imaging of melanocytic skin lesions in patients with multiple atypical nevi. Arch Dermatol 2001, 137:1590-1595.
33. Marghoob A.A., Kopf A.W., Rigel D.S., et al. Risk of cutaneous malignant melanoma in patients with "classic" atypical-mole syndrome. A case-control study. Arch Dermatol 1994, 130:993-998.
34. Salerni G., Lovatto L., Carrera C., et al. Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit. Arch Dermatol 2011, 147:549-555.
35. Argenziano G., Mordente I., Ferrara G., et al. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol 2008, 159:331-336.
36. Salerni G., Carrera C., Lovatto L., et al. Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma. JAm Acad Dermatol 2011, 67(1):e17-e27.
37. Schiffner R., Schiffner-Rohe J., Landthaler M., et al. Long-term dermoscopic follow-up of melanocytic naevi: clinical outcome and patient compliance. Br J Dermatol 2003, 149:79-86.
38. Liu W., Dowling J.P., Murray W.K., et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006, 142:1551-1558.
39. Kelly J.W., Chamberlain A.J., Staples M.P., et al. Nodular melanoma. No longer as simple as ABC. Aust Fam Physician 2003, 32:706-709.
40. Chamberlain A.J., Fritschi L., Kelly J.W. Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. JAm Acad Dermatol 2003, 48:694-701.
41. Menzies S.W., Kreusch J., Byth K., et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol 2008, 144:1120-1127.
42. Argenziano G., Longo C., Cameron A., et al. Blue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma. Br J Dermatol 2011, 165:1251-1255.